WHAT’S NEW
Keep up with the latest from NanoHive Medical, the pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation.
NanoHive Medical Announces $7M Series C Financing and Managing Directors Change
BOSTON, MA, August 5, 2024 - NanoHive Medical, a leader in 3D-printed titanium spinal interbody fusion devices, announces a $7M Series C Financing to capitalize the company’s rapid growth and a priority on company-building to profitability. Outcome Capital served as Strategic and Financial Advisor to NanoHive. The primary use-of-proceeds include: (i) expanding the U.S. commercial organization; (ii) expanding the company’s innovative Hive™ portfolio of Soft Titanium® spinal interbody fusion devices by way of product line-extensions, product launches, and “smart” sensor implant delivery research and development; (iii) entering select international markets; and (iv) expanding strategic...
HD Lifesciences Surpasses 2500 Implant Milestone For Hive™ Interbody Fusion Device
BOSTON, MA - HD Lifesciences, LLC, a medical device company, has announced it has surpassed the milestone of 2500 implanted HIVE interbody devices since the formation of the company in late 2017....
HD LifeSciences Receives 510(k) Clearance for Hive™ ALIF Standalone System
Updated: Feb 2, 2021 - HD LifeSciences has received 510(k) clearance from the U.S Food and Drug Administration (FDA) for its Hive(tm) ALIF Standalone Lumbar Interbody Fusion System. The patented...